← All organizations
Highest phase reached
Phase 3
Acquired by Jazz Pharmaceuticals on Mar 5, 2025
Timeline
2000s
- Jun 1, 2002
Chimerix— Founded
2020s
- Jan 8, 2021
Oncoceutics, Inc.— Acquired
- Jun 4, 2021
brincidofovir— Marketing Organization
- Mar 5, 2025
Jazz Pharmaceuticals— Acquired By
Drugs by trial phase (9 distinct, 40 trials)
Phase 3 (4 own, 1 via acquisition)
Phase 1 (2 own, 2 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (23)
- NCT05392374Lead sponsorN/A—
- NCT06012929CollaboratorPhase 1Jan 31, 2024
- NCT05580562Lead sponsorPhase 3Dec 1, 2022
- NCT05476939CollaboratorPhase 3Sep 29, 2022
- NCT04732065CollaboratorPhase 1Aug 23, 2021
- NCT04571645Lead sponsorPhase 3Jan 30, 2021
- NCT04389840Lead sponsorPhase 2/Phase 3May 31, 2020
- NCT03532035Lead sponsorPhase 2Aug 30, 2018
- NCT03339401Lead sponsorPhase 2Dec 22, 2017
- NCT02596997Lead sponsorN/ANov 3, 2015
- NCT02439957Lead sponsorPhase 3Sep 1, 2015
- NCT02439970Lead sponsorPhase 3Sep 1, 2015
- NCT04268966Lead sponsorPhase 2Oct 31, 2014
- NCT02271347Lead sponsorPhase 2Oct 1, 2014
- NCT02087306Lead sponsorPhase 3Mar 1, 2014
Details
- Founded
- Durham, NC, US Jun 1, 2002
- Last known activity
- Jan 31, 2024